Italy's central bank is pushing back against criticism over how it applies global rules for classifying troubled loans, after an audit helped trigger a sharp sell-off in the shares of invoice-financing specialist BFF. The stock fell 17.6% on Wednesday and is now down more than 80% so far this year, according to Reuters.
The turmoil at BFF, which buys companies' invoices and pays them early—especially for public-sector suppliers in areas like healthcare—highlights how a seemingly technical accounting label can become a major capital problem for a lender.
What happened at BFF?
BFF's business model looks steady on the surface: it advances cash to businesses against their unpaid invoices, earning a fee. But that stability depends on how the company treats late payments. If delays are seen as temporary, the loans remain "performing." If they are seen as a sign that a loan might not be repaid, they must be classified as "impaired."
According to Reuters, an audit earlier this year led to two special administrators being appointed at BFF after a capital shortfall emerged tied to its factoring and lending, including how loans were classified. The company is also reported to be in talks with Cerberus, a US private equity firm, about a potential investment.
The Bank of Italy said it has intervened when lenders misapplied international classification rules, citing issues such as miscounting days past due or labeling a loan "performing" while charging late-payment interest. The central bank's defense comes as investors question whether its oversight was too aggressive or not aggressive enough.
Why loan labels matter
For banks, the distinction between a "performing" and an "impaired" loan is not just semantics. When a supervisor decides that exposures should be treated as impaired, the bank typically has to set aside more money for expected losses. It may also face higher "risk-weighted assets"—a regulator's way of sizing assets by risk—which means the bank must hold more capital against the same loans.
Both effects squeeze a bank's capital ratio, the key measure of financial health that regulators watch closely. If the ratio falls toward minimum requirements, oversight can tighten quickly, and the bank may need to raise fresh capital or shrink its lending.
That is exactly the situation BFF now faces. The key question for investors is not just how big the capital shortfall is under the new treatment, but how quickly the company can rebuild its buffer.
What it means for investors
For bank investors, regulatory decisions can matter more than day-to-day revenue. A single reclassification can wipe out months of earnings and trigger a sharp repricing of risk, as BFF's 17.6% drop shows.
The market's reaction is really a bet on two unknowns: the size of the shortfall and the cost of fixing it. Any potential deal with Cerberus would likely be judged less on valuation and more on whether it brings durable capital headroom.
For everyday investors, the episode is a reminder that banks and financial firms are not just judged on how much they earn, but on how safely they hold capital. A company that looks profitable on paper can still face a sudden crisis if its loan book is riskier than it appeared.
The Bank of Italy's defense of its rules is an attempt to reassure markets that it is enforcing standards consistently. But the BFF case shows that even well-intentioned regulation can create winners and losers, and that investors need to watch not just a company's results, but how its assets are classified.
As BFF works through the aftermath of the audit, and as talks with Cerberus reportedly continue, the focus will remain on the company's capital position and its ability to restore confidence. For now, the market is clearly skeptical.
